Hematopoietic Stem Cells Transplantation Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022, the hematopoietic stem cells transplantation market was valued at USD 3,741.3 Mn in 2015, and is expected to reach USD 7,796.1 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.
Browse Full Report Visit - http://www.acutemarketreports.com/report/hematopoietic-stem-cells-transplantation
Market Insights
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach it may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.
Hematopoietic stem cells are unable to proliferate and differentiate in-vitro. Researchers have yet to evolve an accurate method to differentiate stem cells from other cells derived from blood or bone marrow. Once such technical barriers are overcome, the avenues for realizing the full potential of HSCT. The type of transplant a person receives depends on several different factors, including the type and course of the disease, availability of suitable donors, and the patient’s overall health. There are three different sources of hematopoietic stem cells such as bone marrow, peripheral blood stem cells, and umbilical cord blood. The stem cell source used for a given transplant depends upon the underlying disease, the type of transplant (allogeneic or autologous), and size of the patient.
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach it may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.
Hematopoietic stem cells are unable to proliferate and differentiate in-vitro. Researchers have yet to evolve an accurate method to differentiate stem cells from other cells derived from blood or bone marrow. Once such technical barriers are overcome, the avenues for realizing the full potential of HSCT. The type of transplant a person receives depends on several different factors, including the type and course of the disease, availability of suitable donors, and the patient’s overall health. There are three different sources of hematopoietic stem cells such as bone marrow, peripheral blood stem cells, and umbilical cord blood. The stem cell source used for a given transplant depends upon the underlying disease, the type of transplant (allogeneic or autologous), and size of the patient.
Market Competition Assessment:
The hematopoietic stem cells transplantation market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd., TiGenix N.V., and ScienCell Research Laboratories.
The hematopoietic stem cells transplantation market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH, Cesca Therapeutics Inc., R&D Systems, Genlantis, Lonza Group Ltd., TiGenix N.V., and ScienCell Research Laboratories.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/pharmaceutical-market
Key Market Movements:
• Rising prevalence of leukemia is expected to assist the hematopoietic stem cells transplantation as the survival rates in leukemia patients has been improved after HSCT.
• Future opportunity for HSCT market lies in regenerative Stromal Cell Therapy because it is considered as one of the novel therapies for prevention and treatment of acute graft versus host disease in allogeneic HSCT patients.
• In emerging economies growing government support through providing favorable environments for research laboratories in the field of stem cell research
• Rising prevalence of leukemia is expected to assist the hematopoietic stem cells transplantation as the survival rates in leukemia patients has been improved after HSCT.
• Future opportunity for HSCT market lies in regenerative Stromal Cell Therapy because it is considered as one of the novel therapies for prevention and treatment of acute graft versus host disease in allogeneic HSCT patients.
• In emerging economies growing government support through providing favorable environments for research laboratories in the field of stem cell research
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Hematopoietic Stem Cell Transplantation Market, by Transplantation Type, 2015 v/s 2022 (Value %)
2.2 Global Hematopoietic Stem Cell Transplantation Market, by Application Type, 2015 (USD Mn)
2.3 Global Hematopoietic Stem Cell Transplantation Market, by Geography, 2015 (Value %)
2.1 Global Hematopoietic Stem Cell Transplantation Market, by Transplantation Type, 2015 v/s 2022 (Value %)
2.2 Global Hematopoietic Stem Cell Transplantation Market, by Application Type, 2015 (USD Mn)
2.3 Global Hematopoietic Stem Cell Transplantation Market, by Geography, 2015 (Value %)
Chapter 3 Global Hematopoietic Stem Cells Transplantation Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Increasing Prevalence of Blood Cancer
3.2.2 Better Survival Rates
3.3 Market Restraints
3.3.1 Technical Challenges for Engineering Synthetic HSC Niches at the Nanoscale
3.3.2 Infectious Complications of Hematopoietic Stem Cell Transplantation
3.4 Market Opportunities
3.4.1 Future in Regenerative Stromal Cell Therapy
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Hematopoietic Stem Cells, by Key Players
3.1 Overview
3.2 Market Drivers
3.2.1 Increasing Prevalence of Blood Cancer
3.2.2 Better Survival Rates
3.3 Market Restraints
3.3.1 Technical Challenges for Engineering Synthetic HSC Niches at the Nanoscale
3.3.2 Infectious Complications of Hematopoietic Stem Cell Transplantation
3.4 Market Opportunities
3.4.1 Future in Regenerative Stromal Cell Therapy
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Hematopoietic Stem Cells, by Key Players
Chapter 4 Global Hematopoietic Stem Cells Transplantation Market Analysis, By Transplant Type
4.1 Overview
4.2 Autologous Transplant
4.3 Allogeneic Transplant
4.1 Overview
4.2 Autologous Transplant
4.3 Allogeneic Transplant
Chapter 5 Global Hematopoietic Stem Cells Transplantation Market Analysis, By Applications
5.1 Overview
5.2 Leukemia
5.3 Lymphoproliferative Disorders
5.4 Solid Tumors
5.5 Non-malignant Disorders
5.1 Overview
5.2 Leukemia
5.3 Lymphoproliferative Disorders
5.4 Solid Tumors
5.5 Non-malignant Disorders
Chapter 6 Global Hematopoietic Stem Cells Transplantion Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Latin America
6.6 Middle East and Africa
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Latin America
6.6 Middle East and Africa
To Get Complete Report @ http://www.acutemarketreports.com/report/hematopoietic-stem-cells-transplantation
Chapter 7 Company Profiles
7.1 Escape Therapeutics
7.1.1 Escape Therapeutics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.2 Kite Pharma Inc.
7.2.1 Kite Pharma Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.3 PromoCell GmbH
7.3.1 PromoCell GmbH: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.4 ScienCell Research Laboratories
7.4.1 ScienCell Research Laboratories: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.6 CellGenix Technologie Transfer GmbH
7.6.1 CellGenix Technologie Transfer GmbH: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.7 Cesca Therapeutics Inc.
7.7.1 Cesca Therapeutics Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.1 Escape Therapeutics
7.1.1 Escape Therapeutics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.2 Kite Pharma Inc.
7.2.1 Kite Pharma Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.3 PromoCell GmbH
7.3.1 PromoCell GmbH: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.4 ScienCell Research Laboratories
7.4.1 ScienCell Research Laboratories: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.6 CellGenix Technologie Transfer GmbH
7.6.1 CellGenix Technologie Transfer GmbH: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.7 Cesca Therapeutics Inc.
7.7.1 Cesca Therapeutics Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Latest Reports :
http://www.acutemarketreports.com/report/3d-bioprinters-market
http://www.acutemarketreports.com/report/3d-bioprinters-market
Our Blog :- http://www.newzmarket.com/
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
